NGS-based RNA-seq Market Report

Europe NGS-based RNA-seq Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 11, 2020
  • PAGES：138
  • REPORT CODE：GMM542606
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The NGS-based RNA-seq market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe NGS-based RNA-seq Market Segmentations:

    By Player:

    • Illumina

    • GATC Biotech

    • PerkinElmer

    • Pacific Biosciences of California

    • Eurofins Scientific

    • QIAGEN

    • BGI

    • Oxford Nanopore Technologies

    • Macrogen

    • Thermo Fisher Scientific

    • Agilent Technologies

    • Roche

    By Type:

    • Sample Preparation

    • Sample Preparation, by Method

    • Sequencing Platforms & Consumables for RNA-Seq

    • RNA Sequencing Services

    • Data Analysis, Storage, and Management

    By End-User:

    • De Novo Transcriptome Assembly

    • Expression Profiling Analysis

    • Variant Calling and Transcriptome Epigenetics

    • Small RNA Sequencing

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of NGS-based RNA-seq Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe NGS-based RNA-seq Market Size and Growth Rate of Sample Preparation from 2014 to 2026

    • 1.3.2 Europe NGS-based RNA-seq Market Size and Growth Rate of Sample Preparation, by Method from 2014 to 2026

    • 1.3.3 Europe NGS-based RNA-seq Market Size and Growth Rate of Sequencing Platforms & Consumables for RNA-Seq from 2014 to 2026

    • 1.3.4 Europe NGS-based RNA-seq Market Size and Growth Rate of RNA Sequencing Services from 2014 to 2026

    • 1.3.5 Europe NGS-based RNA-seq Market Size and Growth Rate of Data Analysis, Storage, and Management from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe NGS-based RNA-seq Market Size and Growth Rate of De Novo Transcriptome Assembly from 2014 to 2026

    • 1.4.2 Europe NGS-based RNA-seq Market Size and Growth Rate of Expression Profiling Analysis from 2014 to 2026

    • 1.4.3 Europe NGS-based RNA-seq Market Size and Growth Rate of Variant Calling and Transcriptome Epigenetics from 2014 to 2026

    • 1.4.4 Europe NGS-based RNA-seq Market Size and Growth Rate of Small RNA Sequencing from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of NGS-based RNA-seq Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of NGS-based RNA-seq by Major Types

      • 3.4.1 Market Size and Growth Rate of Sample Preparation

      • 3.4.2 Market Size and Growth Rate of Sample Preparation, by Method

      • 3.4.3 Market Size and Growth Rate of Sequencing Platforms & Consumables for RNA-Seq

      • 3.4.4 Market Size and Growth Rate of RNA Sequencing Services

      • 3.4.5 Market Size and Growth Rate of Data Analysis, Storage, and Management

    4 Segmentation of NGS-based RNA-seq Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of NGS-based RNA-seq by Major End-Users

      • 4.4.1 Market Size and Growth Rate of De Novo Transcriptome Assembly for Construction

      • 4.4.2 Market Size and Growth Rate of Expression Profiling Analysis for Construction

      • 4.4.3 Market Size and Growth Rate of Variant Calling and Transcriptome Epigenetics for Construction

      • 4.4.4 Market Size and Growth Rate of Small RNA Sequencing for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe NGS-based RNA-seq Production Analysis by Top Regions

    • 5.2 Europe NGS-based RNA-seq Consumption Analysis by Top Regions

    • 5.3 Europe NGS-based RNA-seq Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.2 UK NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.3 France NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    6 Product Circulation of NGS-based RNA-seq Market among Top Countries

    • 6.1 Top 5 Export Countries in NGS-based RNA-seq Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in NGS-based RNA-seq Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in NGS-based RNA-seq Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in NGS-based RNA-seq Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in NGS-based RNA-seq Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in NGS-based RNA-seq Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany NGS-based RNA-seq Landscape Analysis

    • 7.1 Germany NGS-based RNA-seq Landscape Analysis by Major Types

    • 7.2 Germany NGS-based RNA-seq Landscape Analysis by Major End-Users

    8. UK NGS-based RNA-seq Landscape Analysis

    • 8.1 UK NGS-based RNA-seq Landscape Analysis by Major Types

    • 8.2 UK NGS-based RNA-seq Landscape Analysis by Major End-Users

    9. France NGS-based RNA-seq Landscape Analysis

    • 9.1 France NGS-based RNA-seq Landscape Analysis by Major Types

    • 9.2 France NGS-based RNA-seq Landscape Analysis by Major End-Users

    10. Italy NGS-based RNA-seq Landscape Analysis

    • 10.1 Italy NGS-based RNA-seq Landscape Analysis by Major Types

    • 10.2 Italy NGS-based RNA-seq Landscape Analysis by Major End-Users

    11. Spain NGS-based RNA-seq Landscape Analysis

    • 11.1 Spain NGS-based RNA-seq Landscape Analysis by Major Types

    • 11.2 Spain NGS-based RNA-seq Landscape Analysis by Major End-Users

    12. Poland NGS-based RNA-seq Landscape Analysis

    • 12.1 Poland NGS-based RNA-seq Landscape Analysis by Major Types

    • 12.2 Poland NGS-based RNA-seq Landscape Analysis by Major End-Users

    13. Russia NGS-based RNA-seq Landscape Analysis

    • 13.1 Russia NGS-based RNA-seq Landscape Analysis by Major Types

    • 13.2 Russia NGS-based RNA-seq Landscape Analysis by Major End-Users

    14. Switzerland NGS-based RNA-seq Landscape Analysis

    • 14.1 Switzerland NGS-based RNA-seq Landscape Analysis by Major Types

    • 14.2 Switzerland NGS-based RNA-seq Landscape Analysis by Major End-Users

    15. Turkey NGS-based RNA-seq Landscape Analysis

    • 15.1 Turkey NGS-based RNA-seq Landscape Analysis by Major Types

    • 15.2 Turkey NGS-based RNA-seq Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Landscape Analysis by Top Countries

      • 16.3.1 Denmark NGS-based RNA-seq Market Volume and Growth Rate

      • 16.3.2 Finland NGS-based RNA-seq Market Volume and Growth Rate

      • 16.3.3 Norway NGS-based RNA-seq Market Volume and Growth Rate

      • 16.3.4 Sweden NGS-based RNA-seq Market Volume and Growth Rate

      • 16.3.6 Iceland NGS-based RNA-seq Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Landscape Analysis by Top Countries

      • 17.3.1 Belgium NGS-based RNA-seq Market Volume and Growth Rate

      • 17.3.2 Netherlands NGS-based RNA-seq Market Volume and Growth Rate

      • 17.3.3 Luxembourg NGS-based RNA-seq Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Landscape Analysis by Top Countries

      • 18.3.1 Estonia NGS-based RNA-seq Market Volume and Growth Rate

      • 18.3.2 Latvia NGS-based RNA-seq Market Volume and Growth Rate

      • 18.3.3 Lithuania NGS-based RNA-seq Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Illumina

      • 19.1.1 Illumina Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 GATC Biotech

      • 19.2.1 GATC Biotech Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 PerkinElmer

      • 19.3.1 PerkinElmer Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Pacific Biosciences of California

      • 19.4.1 Pacific Biosciences of California Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Eurofins Scientific

      • 19.5.1 Eurofins Scientific Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 QIAGEN

      • 19.6.1 QIAGEN Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 BGI

      • 19.7.1 BGI Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Oxford Nanopore Technologies

      • 19.8.1 Oxford Nanopore Technologies Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Macrogen

      • 19.9.1 Macrogen Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Thermo Fisher Scientific

      • 19.10.1 Thermo Fisher Scientific Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Agilent Technologies

      • 19.11.1 Agilent Technologies Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Roche

      • 19.12.1 Roche Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 107 Figures and 159 Tables)

    • Figure Product Picture

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Sample Preparation Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Sample Preparation, by Method Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Sequencing Platforms & Consumables for RNA-Seq Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of RNA Sequencing Services Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Data Analysis, Storage, and Management Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of De Novo Transcriptome Assembly from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Expression Profiling Analysis from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Variant Calling and Transcriptome Epigenetics from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Small RNA Sequencing from 2014 to 2026

    • Figure Germany NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure UK NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure France NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Italy NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Spain NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Poland NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Russia NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Canada NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Finland NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Norway NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania NGS-based RNA-seq Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of NGS-based RNA-seq Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of NGS-based RNA-seq

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of NGS-based RNA-seq by Different Types from 2014 to 2026

    • Table Consumption Share of NGS-based RNA-seq by Different Types from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Sample Preparation Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Sample Preparation, by Method Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Sequencing Platforms & Consumables for RNA-Seq Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of RNA Sequencing Services Market, 2015 - 2026 (USD Million)

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Data Analysis, Storage, and Management Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of NGS-based RNA-seq by Different End-Users from 2014 to 2026

    • Table Consumption Share of NGS-based RNA-seq by Different End-Users from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of De Novo Transcriptome Assembly from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Expression Profiling Analysis from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Variant Calling and Transcriptome Epigenetics from 2014 to 2026

    • Figure NGS-based RNA-seq Market Size and Growth Rate of Small RNA Sequencing from 2014 to 2026

    • Table Europe NGS-based RNA-seq Production by Major Regions

    • Table Europe NGS-based RNA-seq Production Share by Major Regions

    • Figure Europe NGS-based RNA-seq Production Share by Major Countries and Regions in 2014

    • Table Europe NGS-based RNA-seq Consumption by Major Regions

    • Table Europe NGS-based RNA-seq Consumption Share by Major Regions

    • Table Germany NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table UK NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table France NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Italy NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Spain NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Poland NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Russia NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Switzerland NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Turkey NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in NGS-based RNA-seq Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in NGS-based RNA-seq Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in NGS-based RNA-seq Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in NGS-based RNA-seq Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Germany NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Germany NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Germany NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table UK NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table UK NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table UK NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table UK NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table France NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table France NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table France NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table France NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Italy NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Italy NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Italy NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Italy NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Spain NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Spain NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Spain NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Spain NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Poland NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Poland NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Poland NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Poland NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Russia NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Russia NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Russia NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Russia NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Switzerland NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Switzerland NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Switzerland NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Turkey NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Turkey NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Turkey NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Turkey NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NGS-based RNA-seq Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NGS-based RNA-seq Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NGS-based RNA-seq Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries NGS-based RNA-seq Market Volume and Growth Rate from 2014 to 2026

    • Table Illumina Profiles

    • Table Illumina Production, Value, Price, Gross Margin 2014-2019

    • Table Illumina Product benchmarking

    • Table Illumina Strategic initiatives

    • Table Illumina SWOT analysis

    • Table GATC Biotech Profiles

    • Table GATC Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table GATC Biotech Product benchmarking

    • Table GATC Biotech Strategic initiatives

    • Table GATC Biotech SWOT analysis

    • Table PerkinElmer Profiles

    • Table PerkinElmer Production, Value, Price, Gross Margin 2014-2019

    • Table PerkinElmer Product benchmarking

    • Table PerkinElmer Strategic initiatives

    • Table PerkinElmer SWOT analysis

    • Table Pacific Biosciences of California Profiles

    • Table Pacific Biosciences of California Production, Value, Price, Gross Margin 2014-2019

    • Table Pacific Biosciences of California Product benchmarking

    • Table Pacific Biosciences of California Strategic initiatives

    • Table Pacific Biosciences of California SWOT analysis

    • Table Eurofins Scientific Profiles

    • Table Eurofins Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Eurofins Scientific Product benchmarking

    • Table Eurofins Scientific Strategic initiatives

    • Table Eurofins Scientific SWOT analysis

    • Table QIAGEN Profiles

    • Table QIAGEN Production, Value, Price, Gross Margin 2014-2019

    • Table QIAGEN Product benchmarking

    • Table QIAGEN Strategic initiatives

    • Table QIAGEN SWOT analysis

    • Table BGI Profiles

    • Table BGI Production, Value, Price, Gross Margin 2014-2019

    • Table BGI Product benchmarking

    • Table BGI Strategic initiatives

    • Table BGI SWOT analysis

    • Table Oxford Nanopore Technologies Profiles

    • Table Oxford Nanopore Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Oxford Nanopore Technologies Product benchmarking

    • Table Oxford Nanopore Technologies Strategic initiatives

    • Table Oxford Nanopore Technologies SWOT analysis

    • Table Macrogen Profiles

    • Table Macrogen Production, Value, Price, Gross Margin 2014-2019

    • Table Macrogen Product benchmarking

    • Table Macrogen Strategic initiatives

    • Table Macrogen SWOT analysis

    • Table Thermo Fisher Scientific Profiles

    • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Thermo Fisher Scientific Product benchmarking

    • Table Thermo Fisher Scientific Strategic initiatives

    • Table Thermo Fisher Scientific SWOT analysis

    • Table Agilent Technologies Profiles

    • Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Agilent Technologies Product benchmarking

    • Table Agilent Technologies Strategic initiatives

    • Table Agilent Technologies SWOT analysis

    • Table Roche Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Roche Product benchmarking

    • Table Roche Strategic initiatives

    • Table Roche SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US